Personalised computational cardiology: Patient-specific modelling in cardiac mechanics and biomaterial injection therapies for myocardial infarction
- 1.9k Downloads
Predictive computational modelling in biomedical research offers the potential to integrate diverse data, uncover biological mechanisms that are not easily accessible through experimental methods and expose gaps in knowledge requiring further research. Recent developments in computing and diagnostic technologies have initiated the advancement of computational models in terms of complexity and specificity. Consequently, computational modelling can increasingly be utilised as enabling and complementing modality in the clinic—with medical decisions and interventions being personalised. Myocardial infarction and heart failure are amongst the leading causes of death globally despite optimal modern treatment. The development of novel MI therapies is challenging and may be greatly facilitated through predictive modelling. Here, we review the advances in patient-specific modelling of cardiac mechanics, distinguishing specificity in cardiac geometry, myofibre architecture and mechanical tissue properties. Thereafter, the focus narrows to the mechanics of the infarcted heart and treatment of myocardial infarction with particular attention on intramyocardial biomaterial delivery.
KeywordsCardiac disease Finite-element method Subject specific Computational model Ischaemic heart disease Heart failure
Cardiovascular diseases are the single leading cause of death worldwide, accounting for 30 % of all human mortality . Despite recent advances in pharmaceutical, surgical, device and tissue-engineered therapy strategies, cardiovascular diseases remain one of the most costly, common and deadly medical conditions. Since predicted mortality of cardiovascular diseases is projected to increase, it is expected to remain the leading cause of death globally [1, 2].
Computational models can provide a unique framework for assessing efficacy of therapy approaches with relatively low resources: Therapeutic parameters can be easily modified and assessed in multiple concurrent in silico experiments, and computational sensitivity studies are easily conducted to optimise treatment efficacy. Advancing research and technologies have sparked a great deal of interest in integrating FE models into the clinical environment. This is becoming more achievable each year, making it likely that computational models will serve as the first line of the screening for future therapies in the years to come .
This review aims at contextualising the advances and challenges of patient-specific computational modelling with particular focus on cardiac and infarct mechanics and the translation of therapeutic concepts, based on intramyocardial biomaterial injections, for the myocardial infarction (MI) and infarct-induced heart failure (HF). The developments in subject- and patient-specific modelling are detailed with focus on cardiac geometries, myofibre architecture and the constitutive properties of cardiac tissue. Thereafter, the focus narrows on computational modelling of infarct mechanics and therapies for MI, in particular intramyocardial biomaterial injection.
Patient-specific modelling of cardiac mechanics
Anatomical simplification needs to balance model accuracy and computational demands. Until recently, this motivated the use of simplified left ventricular (LV) geometries introduced by various groups [7, 8, 9] as the primary computational tool for investigating cardiac mechanics. The use of patient-specific realistic geometries has, however, become prevalent in computational models (Fig. 1b). This shift towards realistic geometries is indicative of the goal to create more representative computational models for use in clinical decision support.
The first three-dimensional patient-specific computational geometry of a heart was introduced by Okajima et al.  to study electrical activation. It took over two decades for deformable computational finite-element (FE) approaches to incorporate realistic heart geometries . Nielsen et al.  presented a realistic biventricular model that was novel for its accurate geometric description and definition of myofibre orientation. Stevens et al.  extended the model to account, in part, for the four valves. Since then, realistic geometrical models have become increasingly popular. The Living Heart Project recently developed the first full heart model that features a four-chamber human heart geometry with the four valves and the connecting large vessels .
To date, patient-specific cardiac geometries have been introduced as representative cases as proof of concept that a given computational approach can be applied in a patient-specific framework. Extending the concept to computational studies with a large number of patient-specific geometries could generate statistically meaningful results for a patient population. An alternative approach is to utilise a statistically averaged geometry that is representative of a patient population .
The myofibre orientation has a critical influence on cardiac mechanics and electrophysiology. However, the description of myofibre orientation is a highly intricate and sophisticated task, which has been the subject of substantial historical disagreement [16, 17, 18]. The intricacy stems from the complex multiscale branching and merging of cardiac myocytes at microscopic scale, creating anisotropy at tissue level that changes dramatically throughout the structure. An accurate numerical portrayal of the myofibre architecture needs to incorporate the one-dimensional directional tangent of the myofibre and the description of the fibre sheets [18, 19, 20] which influences both passive and active material behaviour.
In recent work, two methods are predominant in describing the myofibre orientation in patient-specific cardiac models: Rule-based reconstructions and fibre orientation derived from diffusion tensor magnetic resonance imaging (DTMRI). Rule-based approaches typically describe the fibre orientation analytically or through aggregated experimental data, whereby a dense fibre orientation field is constructed through interpolation functions [21, 22]. This has recently been cast in the form of a boundary value problem, whereby the fibre orientation is prescribed along the surfaces of the ventricular structure and solved for throughout the geometry . Rule-based reconstructions can be advantageous in their application to highly irregular geometries and their efficient implementation. In DTMRI approaches, the myofibre orientation is calculated from the eigenvectors of diffusion tensors. Due to the challenges of in vivo cardiac DTMRI, this method is often limited to a single post mortem data set. In this case, the derived fibre orientations are projected (or mapped) onto other subject- or patient-specific geometries obtained from computed tomography (CT) or magnetic resonance imaging (MRI) [24, 25]. Toussaint et al.  recently captured in vivo patient-specific myofibre orientation data and integrated these data in other LV models of other patients. This approach involved diffeomorphic data transformations between a realistic geometry and the prolate spheroidal coordinate system.
Considering the sensitivity of FE predictions to variations in fibre orientation [27, 28, 29], it is preferable to incorporate patient-specific DTMRI data whenever possible. DTMRI is, however, still limited as the diffusion tensor characterises only the mean myofibre structure in a voxel volume. Improved accuracy may be achieved by increased spatial resolution of the DTMRI scan or by including a dispersion parameter accounting for the deviation of the fibre orientation within in a voxel. Whereas homogenous dispersion has been considered in modelling myocardial tissue , dispersion at voxel scale has not yet been considered. Toussaint et al.  in vivo DTMRI analysis is the most advanced approach at present. No computational models have investigated cardiac function using truly individual patient-specific fibre orientation.
The notation and material parameters detailed by Holzapfel and Ogden  have become the most widely used form of a passive material law for cardiac mechanics, often recalibrated with new material parameters [22, 39, 40]. The incompressibility of the material is handled through a penalty function A incomp, of which multiple variations exist, and which is often implemented through mixed formulation methods, splitting the deformation into isochoric and deviatoric components.
The incorporation of active tension into a mathematical description to capture the contractile behaviour of the heart is a significant task. The most common approach, introduced by Guccione et al. , relies on additive contribution of the active stress to the overall material stress, typically along the local fibre orientation. Active tension can be constructed using various physiologically meaningful parameters, which has been employed by many studies [14, 39, 42, 43]. Another emerging approach involves multiplicative decomposition of the tensor gradient of deformation [44, 45, 46], in a similar fashion to the theory of volumetric growth. Multiplicative decomposition is more mathematically robust, whereas the additive approach can capture physiological phenomena more meaningfully. The latter is due to a more flexible formulation that allows for parameter calibration on a tensor component level [44, 45]. Contractile material behaviour can be coupled within an electromechanical framework, whereby a more realistic excitation–contraction pattern is incorporated into the model. Over the last decade, this multi-physics coupling has been introduced with great success in various computational models [47, 48, 49, 50, 51, 52, 53].
It is impossible to meaningfully determine the three-dimensional patient-specific material properties from ventricular pressure–volume relationships alone . To remedy this, the identification of suitable values for the constitutive parameters (sometimes called calibration) often utilises additional data. In vitro biaxial and shear stress–strain experiments [55, 56] on cardiac tissue have been used to calibrate numerous constitutive laws. The reliability of in vitro experiments may be questionable due to tissue damage or disruption in the process of extraction . Inclusion of in vivo data in material calibration provides a more realistic mechanical environment for loading and deformation . Obtaining these stress–strain data from magnetic resonance electrography (MRE) or tagged MRI provides additional advantages whereby patient-specific information can be captured into the constitutive law through optimisation approaches [24, 54, 59, 60, 61]. This approach has recently been extended to additionally estimate infarct material parameters [62, 63]. Considering the anatomical variability amongst patients, it becomes increasingly attractive to calibrate material laws for geometrically consistent in vivo data, i.e., local stress–strain data for the same geometry and fibre distribution—an inherently patient- or subject-specific process that can easily be adopted to handle cardiac pathologies, e.g., MI.
Modelling of MI treatments
Noninvasive assessment of the heart after MI is essential for optimal treatment. Local wall stress, in particular, can be a key factor in assessing cardiac function and predict post-MI effects, yet wall stress cannot be measured systematically and quantitatively with clinical modalities . Imaging techniques provide high accuracy information regarding the strain distribution in the heart, yet cannot provide local stress information. Laplace’s law, used to estimate cardiac wall stress, makes considerable assumptions with respect to the cardiac structure and provides considerably different results to anatomically accurate FE models .
FE models have been labelled as the most versatile approach for quantitatively predicting myocardial stress and strain distributions [66, 67]. The effects of MI on structure and function of the heart have received increasing attention for FE modelling. The understanding of the aforementioned is essential when developing a treatment to restore cardiac function and to attenuate adverse post-infarct remodelling. Simulating MI in silico allows the influence on heart to be directly quantified [46, 68, 69, 70, 71], providing deeper insight into the underlying mechanisms involved. For example, by complementing a study on dosage efficacy of the ACE inhibitor ramipril, FE models showed that apical wall stress is an independent predictor of ventricular remodelling .
Modelling of material injection therapies for MI
There has been significant recent interest in intramyocardial biomaterial injections as therapy for MI, whereby predominantly the infarcted region of the heart is injected with a biomaterial which aims to inhibit the adverse remodelling that leads to HF. Injectable biomaterials are showing promise in preclinical studies [85, 86, 87, 88, 89, 90, 91, 92], resulting in a range of improvements to cardiac repair, with respect to wall thickness, ejection fraction and ventricular volume. Further research on the specific mechanisms by which these biomaterials improve cardiac function is needed to aid the development of more effective treatment.
Research into cardiac injection therapy has become diverse due to the choice of injectable material and the delivery method from a range of viable options [93, 94]. Due to this, the representation of intramyocardial biomaterial injectates in computational models relies on either homogenisation approaches, whereby the injected material is averaged in the description of the myocardium wall, or through geometric approaches, whereby the injections are considered separate inclusions embedded within the wall.
Lee et al.  investigated a combination treatment of biomaterial injections and coronary artery bypass grafting with patient-specific models developed from MRI data of three patients suffering with HF. Simulating a longitudinal study with pre-treatment and three- and six-months post-treatment time points revealed a more uniform distribution and 35 % reduction in myofibre stress throughout the LV.
Advances in patient-specific computational cardiac mechanics over the last decade have been significant in almost every aspect. The quality of imaging and segmentation techniques coupled with increasing computational resources have allowed for unprecedented growth. Geometrically realistic multi-physics models are becoming the new standard of computational cardiology. As structural and functional data of the heart become more easily available, the calibration and validation of these models becomes more reliable.
Patient-specific models hold promise for personalising diagnosis, treatment planning and therapy design. The example of SVR emphasises that interventions based on accurate patient-specific information have clear advantages over treatments that are not personalised. Large-cohort patient-specific computational studies, simulating treatments in silico, will also be able to unlock novel and statistically meaningful findings for entire patient populations—something that cannot be achieved with a small number of computational models. The ability to re-use computational models, perturb parameters and perform sensitivity studies will not only provide an unprecedented wealth of information in the aid of therapy design but can also accelerate the translation of therapy approaches into the clinical setting.
Despite these advantages, there has yet to be a single high-resolution patient-specific computational cardiac model, constructed and calibrated using data from a single patient. Accounting for patient-specific myofibre structure and calibrating material laws using comprehensive in vivo data are still largely lacking in computational models investigating cardiac mechanics.
While recent computational research on biomaterial injection MI therapies has made substantial progress, more work is needed to further elucidate the mechanisms underlying the benefits observed. The local and global changes in myocardial tissue structure after MI, including necrosis, fibrosis and scar formation, and the representation in computational models are one area that need to receive increased attention. Pending availability of experimental data, advanced numerical methods to model growth [107, 108, 109] and tissue healing  may be adaptable to computationally describe MI-related “reverse” growth and remodelling. This will allow to study in more detail the effects of biomaterial injectates on tissue changes which may provide additional therapeutic cues. A related challenge is the realistic representation of in situ injectate geometries, in particular when biomaterial infiltrates the myocardium at microscopic level [89, 90, 97]. Also yet unconsidered in computational models are injection therapies with mechanobiological targets such as fibroblast reprogramming [111, 112] and stem cell therapies [113, 114].
Realistic predictive patient-specific computational models require comprehensive in vivo data for calibration and validation. In the context of cardiac diseases and therapies, current in vivo imaging technologies are not yet advanced enough to provide such patient-specific data as part of the clinical diagnostic modalities. Until cutting-edge modalities such as in vivo cardiac DTMRI become more available in the clinic routine, the pursuit of fully subject-specific computational modelling remains limited to preclinical research, where a richer resource of in vivo and ex vivo data can be utilised. Subject-specific computational modelling can, however, offer great potential to complement experimental research and can play a crucial role in advancing biomaterial injection therapies for MI.
The authors thank Pamela Derish in the Department of Surgery, University of California San Francisco for proofreading the manuscript. Financial support was provided by the South African National Research Foundation (to TF and KS), the Oppenheimer Memorial Trust (to KS), the South African Medical Research Council (to NHD) and the National Institutes of Health (to JMG; Grants R01HL-077921 and R01HL-118627 and U01HL-119578). Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors, and therefore, the NRF does not accept any liability in this regard thereto.
- 1.WHO (2011) Global status report on noncommunicable diseases 2010: Description of the global burden of NCDs, their risk factors and determinants. World Health Organization, GenevaGoogle Scholar
- 22.Genet M, Lee LC, Nguyen R, Haraldsson H, Acevedo-Bolton G, Zhang Z, Ge L, Ordovas K, Kozerke S, Guccione JM (2014) Distribution of normal human left ventricular myofiber stress at end-diastole and end-systole-a target for in silico design of heart failure treatments. J Appl Physiol 117(2):142–152. doi: 10.1152/japplphysiol.00255.2014 PubMedPubMedCentralCrossRefGoogle Scholar
- 28.Chen J, Liu W, Zhang H, Lacy L, Yang X, Song SK, Wickline SA, Yu X (2005) Regional ventricular wall thickening reflects changes in cardiac fiber and sheet structure during contraction: quantification with diffusion tensor MRI. Am J Physiol Heart Circ Physiol 289(5):H1898–1907. doi: 10.1152/ajpheart.00041.2005 PubMedCrossRefGoogle Scholar
- 37.Usyk T, McCulloch A (2003) Computational methods for soft tissue biomechanics. In: Holzapfel G, Ogden R (eds) Biomechanics of soft tissue in cardiovascular systems, vol 441. International Centre for Mechanical Sciences. Springer Vienna, pp 273–342. doi: 10.1007/978-3-7091-2736-0_7
- 43.Lee LC, Ge L, Zhang Z, Pease M, Nikolic SD, Mishra R, Ratcliffe MB, Guccione JM (2014) Patient-specific finite element modeling of the Cardiokinetix Parachute® device: effects on left ventricular wall stress and function. Med Biol Eng Comput 52(6):557–566. doi: 10.1007/s11517-014-1159-5 PubMedPubMedCentralCrossRefGoogle Scholar
- 53.Rosolen AM, Ordas S, Vazquez M, Frangi AF (2006) Numerical schemes for the simulation of three-dimensional cardiac electrical propagation in patient-specific ventricular geometries. Paper presented at the European conference on computational fluid dynamics ECCOMAS CFD 2006Google Scholar
- 54.Sun K, Stander N, Jhun CS, Zhang Z, Suzuki T, Wang GY, Saeed M, Wallace AW, Tseng EE, Baker AJ, Saloner D, Einstein DR, Ratcliffe MB, Guccione JM (2009) A computationally efficient formal optimization of regional myocardial contractility in a sheep with left ventricular aneurysm. J Biomech Eng 131(11):111001. doi: 10.1115/1.3148464 PubMedPubMedCentralCrossRefGoogle Scholar
- 59.Xi J, Lamata P, Niederer S, Land S, Shi W, Zhuang X, Ourselin S, Duckett SG, Shetty AK, Rinaldi CA, Rueckert D, Razavi R, Smith NP (2013) The estimation of patient-specific cardiac diastolic functions from clinical measurements. Med Image Anal 17(2):133–146. doi: 10.1016/j.media.2012.08.001 PubMedCrossRefGoogle Scholar
- 62.Mojsejenko D, McGarvey JR, Dorsey SM, Gorman JH 3rd, Burdick JA, Pilla JJ, Gorman RC, Wenk JF (2015) Estimating passive mechanical properties in a myocardial infarction using MRI and finite element simulations. Biomech Model Mechanobiol 14(3):633–647. doi: 10.1007/s10237-014-0627-z PubMedCrossRefGoogle Scholar
- 63.McGarvey JR, Mojsejenko D, Dorsey SM, Nikou A, Burdick JA, Gorman JH III, Jackson BM, Pilla JJ, Gorman RC, Wenk JF (2015) Temporal changes in infarct material properties: an in vivo assessment using magnetic resonance imaging and finite element simulations. Ann Thorac Surg 100(2):582–590. doi: 10.1016/j.athoracsur.2015.03.015 PubMedCrossRefGoogle Scholar
- 65.Zhang Z, Tendulkar A, Sun K, Saloner DA, Wallace AW, Ge L, Guccione JM, Ratcliffe MB (2011) Comparison of the Young-Laplace law and finite element based calculation of ventricular wall stress: implications for postinfarct and surgical ventricular remodeling. Ann Thorac Surg 91(1):150–156. doi: 10.1016/j.athoracsur.2010.06.132 PubMedPubMedCentralCrossRefGoogle Scholar
- 66.Shimkunas R, Zhang Z, Wenk JF, Soleimani M, Khazalpour M, Acevedo-Bolton G, Wang G, Saloner D, Mishra R, Wallace AW (2013) Left ventricular myocardial contractility is depressed in the borderzone after posterolateral myocardial infarction. Ann Thorac Surg 95(5):1619–1625PubMedPubMedCentralCrossRefGoogle Scholar
- 67.Wenk JF, Eslami P, Zhang Z, Xu C, Kuhl E, Gorman JH 3rd, Robb JD, Ratcliffe MB, Gorman RC, Guccione JM (2011) A novel method for quantifying the in vivo mechanical effect of material injected into a myocardial infarction. Ann Thorac Surg 92(3):935–941. doi: 10.1016/j.athoracsur.2011.04.089 PubMedPubMedCentralCrossRefGoogle Scholar
- 71.Kerckhoffs RC, Neal ML, Gu Q, Bassingthwaighte JB, Omens JH, McCulloch AD (2007) Coupling of a 3D finite element model of cardiac ventricular mechanics to lumped systems models of the systemic and pulmonic circulation. Ann Biomed Eng 35(1):1–18. doi: 10.1007/s10439-006-9212-7 PubMedCrossRefGoogle Scholar
- 72.Aikawa Y, Rohde L, Plehn J, Greaves SC, Menapace F, Arnold MO, Rouleau JL, Pfeffer MA, Lee RT, Solomon SD (2001) Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis. Am Heart J 141(2):234–242PubMedCrossRefGoogle Scholar
- 74.Dang AB, Guccione JM, Zhang P, Wallace AW, Gorman RC, Gorman JH 3rd, Ratcliffe MB (2005) Effect of ventricular size and patch stiffness in surgical anterior ventricular restoration: a finite element model study. Ann Thorac Surg 79(1):185–193. doi: 10.1016/j.athoracsur.2004.06.007 PubMedCrossRefGoogle Scholar
- 75.Lee LC, Wenk JF, Zhong L, Klepach D, Zhang Z, Ge L, Ratcliffe MB, Zohdi TI, Hsu E, Navia JL, Kassab GS, Guccione JM (2013) Analysis of patient-specific surgical ventricular restoration: importance of an ellipsoidal left ventricular geometry for diastolic and systolic function. J Appl Physiol 115(1):136–144. doi: 10.1152/japplphysiol.00662.2012 (1985) PubMedPubMedCentralCrossRefGoogle Scholar
- 76.Zhong L, Su Y, Gobeawan L, Sola S, Tan RS, Navia JL, Ghista DN, Chua T, Guccione J, Kassab GS (2011) Impact of surgical ventricular restoration on ventricular shape, wall stress, and function in heart failure patients. Am J Physiol Heart Circ Physiol 300(5):H1653–H1660. doi: 10.1152/ajpheart.00021.2011 PubMedPubMedCentralCrossRefGoogle Scholar
- 77.Athanasuleas CL, Stanley AW Jr, Buckberg GD, Dor V, DiDonato M, Blackstone EH (2001) Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. reconstructive endoventricular surgery, returning torsion original radius elliptical shape to the LV. J Am Coll Cardiol 37(5):1199–1209PubMedCrossRefGoogle Scholar
- 79.Wenk JF, Ge L, Zhang Z, Mojsejenko D, Potter DD, Tseng EE, Guccione JM, Ratcliffe MB (2013) Biventricular finite element modeling of the Acorn CorCap Cardiac Support Device on a failing heart. Ann Thorac Surg 95(6):2022–2027. doi: 10.1016/j.athoracsur.2013.02.032 PubMedPubMedCentralCrossRefGoogle Scholar
- 80.Mazzaferri EL Jr, Gradinac S, Sagic D, Otasevic P, Hasan AK, Goff TL, Sievert H, Wunderlich N, Nikolic SD, Abraham WT (2012) Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: results of the percutaneous ventricular restoration in chronic heart failure patients trial. Am Heart J 163(5):812–820. doi: 10.1016/j.ahj.2012.02.013 (e811) PubMedCrossRefGoogle Scholar
- 82.Wong VM, Wenk JF, Zhang Z, Cheng G, Acevedo-Bolton G, Burger M, Saloner DA, Wallace AW, Guccione JM, Ratcliffe MB, Ge L (2012) The effect of mitral annuloplasty shape in ischemic mitral regurgitation: a finite element simulation. Ann Thorac Surg 93(3):776–782. doi: 10.1016/j.athoracsur.2011.08.080 PubMedPubMedCentralCrossRefGoogle Scholar
- 83.Carrick R, Ge L, Lee LC, Zhang Z, Mishra R, Axel L, Guccione JM, Grossi EA, Ratcliffe MB (2012) Patient-specific finite element-based analysis of ventricular myofiber stress after Coapsys: importance of residual stress. Ann Thorac Surg 93(6):1964–1971. doi: 10.1016/j.athoracsur.2012.03.001 PubMedPubMedCentralCrossRefGoogle Scholar
- 84.Wenk JF, Zhang Z, Cheng G, Malhotra D, Acevedo-Bolton G, Burger M, Suzuki T, Saloner DA, Wallace AW, Guccione JM, Ratcliffe MB (2010) First finite element model of the left ventricle with mitral valve: insights into ischemic mitral regurgitation. Ann Thorac Surg 89(5):1546–1553. doi: 10.1016/j.athoracsur.2010.02.036 PubMedPubMedCentralCrossRefGoogle Scholar
- 88.Plotkin M, Vaibavi SR, Rufaihah AJ, Nithya V, Wang J, Shachaf Y, Kofidis T, Seliktar D (2014) The effect of matrix stiffness of injectable hydrogels on the preservation of cardiac function after a heart attack. Biomaterials 35(5):1429–1438. doi: 10.1016/j.biomaterials.2013.10.058 PubMedCrossRefGoogle Scholar
- 91.Sabbah HN, Wang M, Gupta RC, Rastogi S, Ilsar I, Sabbah MS, Kohli S, Helgerson S, Lee RJ (2013) Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. JACC Heart Fail 1(3):252–258PubMedPubMedCentralCrossRefGoogle Scholar
- 92.Dorsey SM, McGarvey JR, Wang H, Nikou A, Arama L, Koomalsingh KJ, Kondo N, Gorman JH III, Pilla JJ, Gorman RC, Wenk JF, Burdick JA (2015) MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction. Biomaterials 69:65–75. doi: 10.1016/j.biomaterials.2015.08.011 PubMedCrossRefGoogle Scholar
- 97.Ifkovits JL, Tous E, Minakawa M, Morita M, Robb JD, Koomalsingh KJ, Gorman JH, Gorman RC, Burdick JA (2010) Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci USA 107(25):11507–11512PubMedPubMedCentralCrossRefGoogle Scholar
- 99.Wenk JF, Wall ST, Peterson RC, Helgerson SL, Sabbah HN, Burger M, Stander N, Ratcliffe MB, Guccione JM (2009) A method for automatically optimizing medical devices for treating heart failure: designing polymeric injection patterns. J Biomech Eng 131(12):121011. doi: 10.1115/1.4000165 PubMedCrossRefGoogle Scholar
- 102.Kortsmit J, Davies NH, Miller R, Macadangdang JR, Zilla P, Franz T (2013) The effect of hydrogel injection on cardiac function and myocardial mechanics in a computational post-infarction model. Comput Methods Biomech Biomed Eng 16(11):1185–1195. doi: 10.1080/10255842.2012.656611 CrossRefGoogle Scholar
- 103.Sirry MS, Davies NH, Kadner K, Dubuis L, Saleh MG, Meintjes EM, Spottiswoode BS, Zilla P, Franz T (2015) Micro-structurally detailed model of a therapeutic hydrogel injectate in a rat biventricular cardiac geometry for computational simulations. Comput Methods Biomech Biomed Eng 18(3):325–331. doi: 10.1080/10255842.2013.793765 CrossRefGoogle Scholar
- 106.Lee LC, Wall ST, Klepach D, Ge L, Zhang Z, Lee RJ, Hinson A, Gorman JH 3rd, Gorman RC, Guccione JM (2013) Algisyl-LVR with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart. Int J Cardiol 168(3):2022–2028. doi: 10.1016/j.ijcard.2013.01.003 PubMedPubMedCentralCrossRefGoogle Scholar
- 114.Amado LC, Saliaris AP, Schuleri KH, John MS, Xie J-S, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102(32):11474–11479PubMedPubMedCentralCrossRefGoogle Scholar
- 115.Baillargeon B, Costa I, Leach J, Lee L, Genet M, Toutain A, Wenk J, Rausch M, Rebelo N, Acevedo-Bolton G, Kuhl E, Navia J, Guccione J (2015) Human cardiac function simulator for the optimal design of a novel annuloplasty ring with a sub-valvular element for correction of ischemic mitral regurgitation. Cardiovasc Eng Tech 6(2):105–116. doi: 10.1007/s13239-015-0216-z CrossRefGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.